Steffen Sammet to Disease-Free Survival
This is a "connection" page, showing publications Steffen Sammet has written about Disease-Free Survival.
Connection Strength
0.062
-
Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome prediction. Magn Reson Imaging. 2014 Dec; 32(10):1198-205.
Score: 0.025
-
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol. 2010 May 10; 28(14):2323-30.
Score: 0.019
-
Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol. 2009 Jun; 44(6):343-50.
Score: 0.018